Product Information
METHYLPREDNISOLONE 8 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.9330 per EA under NDC 68382091711. Its NADAC has been published 418 times since Oct 3, 2018.
FDA first approved this application on Apr 23, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
8 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382091711
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPREDNISOLONEApproval Type
Generic (ANDA)
FDA Application
ANDA206751FDA Approved
4/23/2018
TE Code
AB
On Market Since
5/1/2018
Pharmacological Classes
Price Statistics
The NADAC for METHYLPREDNISOLONE 8 MG TABLET has been published 418 times since Oct 3, 2018, and over the history we have for it it has declined 22.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9330 per EA |
|---|---|
| All-time high | $1.4125 (Nov 13, 2019) |
| All-time low | $0.7954 (May 22, 2024) |
| 52-week high | $1.0323 |
| 52-week low | $0.9149 |
| Median price | $1.1300 |
| Average price | $1.1225 |
| Largest weekly change | +42.4% (Dec 20, 2023) |
| Weeks tracked | 418 |
| Tracking since | Oct 3, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
methylprednisolone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPREDNISOLONE 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPREDNISOLONE 8 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.9330 per EA (NDC 68382091711), effective Sep 30, 2026.
How has the price of METHYLPREDNISOLONE 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHYLPREDNISOLONE 8 MG TABLET has declined 22.6%. It has been tracked across 418 weekly CMS publications since Oct 3, 2018.
What are the highest and lowest recorded NADAC prices for METHYLPREDNISOLONE 8 MG TABLET?
Since Oct 3, 2018, the NADAC for METHYLPREDNISOLONE 8 MG TABLET has ranged from a low of $0.7954 (May 22, 2024) to a high of $1.4125 (Nov 13, 2019), with a median of $1.1300 per EA.
Are there cheaper alternatives to METHYLPREDNISOLONE 8 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as METHYLPREDNISOLONE 8 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METHYLPREDNISOLONE 8 MG TABLET?
METHYLPREDNISOLONE 8 MG TABLET (NDC 68382091711) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.